This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract is for the delivery of XENPOZYME 20 MG VIALS, a pharmaceutical product, with a ceiling value of $109,272.60 and a period of performance through June 4, 2024.
DMS Pharmaceutical Group is a pharmaceutical wholesaler that provides a wide range of pharmaceutical products and medical supplies to support the recurring medical supply needs of military health facilities and VA medical centers. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS and the DLA, valued at up to $499,999,999, that allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items. The contract has no set-aside designation.
Generated 8/12/24, 9:31 AM